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Abstract
Background: Ear infection or otitis media (OM) accounts for most bacterial respiratory infections in children in both
developed and developing nations. Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella
catarrhalis are the major OM pathogens. However, little is known about the genetic basis of bacterial OM largely due to
practical difficulties in conducting research in ear infection models and genetically manipulating clinical isolates. Here, we
report the first genome-scale in vivo screen for bacterial genes required for ear infection in a chinchilla model by signature
tagged mutagenesis (STM), a high throughput mutant screen technique.
Methodology/Principal Findings: STM strains were constructed with a multi-drug resistant OM isolate ST556 (serotype 19F)
and screened in a chinchilla OM model. Out of 5,280 mutants tested, 248 mutants were substantially underrepresented in
the mutant pools recovered from the middle ear fluids of the infected chinchillas, indicating the impaired ability to survive
and replicate in the middle ears due to genetic disruptions in the chromosome of strain ST556. Further DNA sequencing
analysis mapped the mutations to 169 pneumococcal genes. Surprisingly, only 52 of these genes were required for
pneumococcal nasopharyngeal colonization in a murine model. This infection site-specific gene requirement was verified by
targeted mutagenesis in the selected genes.
Conclusions/Significance: These findings suggest that there are a subset of pneumococcal genes required for ear infection
and that these may be distinct from those required for nasal colonization. Our data thus provide comprehensive gene
targets for mechanistic understanding of pneumococcal ear infection. Finally, this study has also developed a model for
future genome-scale search for virulence determinants in other pathogens associated with ear infections.
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Introduction
Acute otitis media (OM) accounts for most bacterial respiratory
infections in children in both developed and developing nations
[1]. Recent surveys suggest that OM is the most common cause for
visits to the emergency room and the second ranking reason for
visits to a physician’s office in the United States (more than 20
million per year) [2]. By three years of age, 80 percent of all
children in the United States have had at least one episode of OM,
and 50 percent have had at least three episodes; the estimated
annual cost associated with OM is over 5 billion dollars in the
United States alone [1]. OM is characterized by excessive mucus
secretion and inflammation with an infiltration of the subperiosteal
space by leukocytes, macrophages and mast cells [1]. In contrast to
the significant impact of the OM on public health, the pathogenic
mechanisms of OM are largely unclear. Some bacterial factors
have been identified to contribute to the OM pathogenesis, but no
study has been conducted to identify virulence determinants at a
genome scale. This situation is partly caused by limited availability
of suitable and convenient animal models [3].
Infections caused by Streptococcus pneumoniae, nontypeable Hae-
mophilus influenzae, and Moraxella catarrhalis account for the majority
of OM [4]. Among the bacterial pathogens, S. pneumoniae is the
most common cause of OM, accounting for approximately 40% of
the episodes [4]. S. pneumoniae is naturally able to colonize in the
human nasopharynx, subsequently causing infection in the middle
ear and other remote tissues [5]. Based on the structural and
antigenic variation of the capsular polysaccharide, S. pneumoniae
isolates have been classified into 91 serotypes [6,7]. OM is
predominately associated with strains from serotypes 3, 6A, 6B,
9V, 14, 19A, 19F, and 23F [8]. S. pneumoniae is also an important
pathogen causing pneumonia, bacteremia, and meningitis.
Treatment of pneumococcal infections depends on the adminis-
tration of antibiotics, but the systematic use of antibiotics has led to
the rapid emergence of multi-drug-resistant pneumococcal isolates
[9]. The current capsular polysaccharide-based vaccines have
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[1].
Previous studies have identified many virulence-associated factors
for pneumococcal nasal colonization, pneumonia, and bacteremia
[5]. In particular, three studies have used signature-tagged
mutagenesis (STM) to identify a large list of pneumococcal genes
that are required for bacterial survival in murine models of
pneumonia [10–12] and bacteremia [11]. In sharp contrast, very
few of the virulence factors identified in other pneumococcal
infection modelshave beenstudiedinOMmodels[13,14].ThenanA
gene encoding the major neuraminidase of S. pneumoniae is required
for ear infection in the chinchilla model [13]. STM was originally
developed to identify virulence factors in Salmonella typhimurium by
negative selection [15]. This technique has been successfully used to
identify virulence-associated genes in many other pathogens [16]. In
this study, we performed an STM screen with a low-passage clinical
isolate in a modified OM chinchilla model. This work led to the
identification of 169 bacterial genes that are potentially required for
ear infection. We further determined that the majority of the genes
are not required for pneumococcal nasal colonization, suggestive of
tissue-specific genetic requirement for ear infection.
Results
Establishment of middle ear infection screen model in
chinchillas
To identify pneumococcal factors that are specifically associated
with OM, we chose to study a low-passage multi-drug resistant
serotype 19F isolate ST556 [8]. 19F is one of the few serotypes that
are commonly associated with OM [8,17]. We first sought to verify
capsule production of ST556 because the capsule is an essential
virulence factor for pneumococcal nasal colonization, pneumonia,
and bacteremia [5]. Electron microscopy analysis showed that
ST556 is indeed encapsulated (Fig. 1A). We also found that ST556 is
transformable by natural transformation, which was essential for
preparingtaggedmutantsforinvivoscreen.Anotherkeyrequirement
for successful STM screen is the ability to recover sufficient numbers
of inoculated bacteria from live animals post infection to allow the
identification of each representative mutant that survives within a
mutant pool [16]. To this end, it is critical to select an appropriate
infection model and parameters. Various animal models including
chinchillaandmouse have been used to studymiddleearinfection of
S. pneumoniae [18]. However, no ear infection models had been used
for a high throughput STM screen. Given its large space and
accessibility of the middle ear, chinchillas were assessed for their
suitability for our STM screen.
To assess bacterial burden profiles at various stages of
pneumococcal infection in the middle ears by a noninvasive
bioluminescent imaging approach [19], we first engineered a
bioluminescent ST556 derivative that carried the luxCDABE gene
cluster of Photorhabdus luminescens. The middle ears of chinchillas
were then infected with various doses of the bioluminescent
pneumococci via tympanotomy. As represented in Fig. 1B,
pneumococci in the middle ear of infected chinchillas became
detectable 24 hr post infection and remained detectable for at least
5 days. Consistent with the nontypeable H. influenzae study [19],
the detection limit of this technique was approximately 10
5 colony-
forming unit (CFU) for S. pneumoniae in the middle ears as
determined by CFU enumeration (data not shown). As judged by
bioluminescence level and CFU count, bacterial burden reached
the highest level (.10
7 CFU/ear) around 3 days post infection
(Fig. 1B). This observation was consistent with the progression of
bacterial burdens in human ear infections in the absence of
antibiotics [20]. All chinchillas were able to survive the infection
with up to 2610
4 CFU of ST556 (data not shown). This resistance
level allowed relatively large infection doses of the mutant pools
thereby maximizing the representation of each mutant in the
inoculums. We also found that the uninoculated ears of the
animals infected through the other ear mostly remained sterile or
contained low levels of the inoculated pneumococci. This
observation allowed us to use both ears of a single animal to
screen the STM strains and thus minimized the number of animals
associated with our STM screen. To further test the feasibility of
this model, we separately infected the left and right ears of two
chinchillas with the same pool of 55 STM strains (10
4 CFU
pneumococci/ear; 182 CFU/mutant/ear). We consistently recov-
ered high levels of the bacterium (.10
5 CFU/ear) from the middle
ear washes of all infected animals 3 days post infection with
minimal mortality. Finally, the mutants that were lost or
underrepresented in one ear were virtually always lost or
underrepresented in the other ear of the same chinchilla.
Therefore, the ‘‘bottleneck’’ issue encountered by Hava et al.
[10] in the lung infection model did not appear to play an
appreciable role in this ear infection model.
Figure 1. Middle ear infection by pneumococcal strain ST556.
(A) Detection of ST556 encapsulation by transmission electron
microscopy. (B) Detection of ST556 infection in the middle ears.
Chinchillas were infected with bioluminescent pneumococci via
tympanotomy and monitored daily for bacterial burden by biolumi-
nescence. The scales on the right indicate the levels of photon counts.
doi:10.1371/journal.pone.0002950.g001
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Tagged mutants of S. pneumoniae ST556 were generated by
insertion duplication with derivatives of the pID701t suicide
plasmid that were used in a previous STM study with a type-3 S.
pneumoniae strain [11]. As shown in Fig. 2A, randomly selected
clones of the E. coli transformants covered a wide range of
pneumococcal chromosomal loci as reflected by various sizes of
DNA inserts after restriction digestion. The recombinant plasmids
were transformed into S. pneumoniae ST556 to generate disruptive
mutations. The Southern blot analysis of selected pneumococcal
mutants indicated that the tagged plasmids were inserted into the
chromosome of strain ST556 in a highly random manner (Fig. 2B).
A total of 5,280 STM strains were arranged in 96 mutant sets
(,55 mutants/set) based on the identity of the sequence tags to
prepare the input pools.
Negative selection and sequence identification of
attenuated mutants in the OM model
The input pools were inoculated into the middle ears of
chinchillas via tympanotomy and selected under the conditions
defined in the preliminary trials. The remaining bacteria (output
pools) were recovered 3 days later by ear lavaging to detect the
presence or absence of individual mutants by polymerase chain
reaction (PCR) using tag-specific primers (Fig. 3A). This procedure
identified 678 strains that were completely missing or substantially
underrepresented in the PCR profiles. To exclude the mutants
with marginal attenuation, the resulting mutants were then
arranged into 20 sets of 29–32 mutants, and subjected to a 2
nd
round of screen in chinchillas. A total of 248 mutants were found
to be completely missing in the 2
nd round screen. These strains are
referred to as attenuated mutants hereafter. Plasmid insertion sites
of the mutants were mapped to 169 genes by DNA sequencing
(Table 1; Table S1). This represents ,9% of the predicted S.
pneumoniae open reading frames (ORF) based on the fully sequenced
genome of TIGR4 [21]. Since the ST556 genome has not yet been
determined,thegenesidentifiedinthisworkareorganizedaccording
to the gene annotations of strain TIGR4. This arrangement has also
allowedcomparative analysisofourdata withthosefromtheTIGR4
STM study [10]. Allelic homologs were found for the majority of the
genes (132, 78%) in the TIGR4 genome, whereas 32 genes are not
shared by TIGR4 (Table S1). We refer to these as ST556-specific
genes in this context.
Consistent with other STM studies [10,11], a large portion of
the identified genes (34; 20.1%) represents transport-associated
functions, many of which encode ABC transporters for carbohy-
drates and amino acids (Table 1). As anticipated, some of the
genes (22, 13%) encode various enzymes that are associated with
cellular processing functions. In agreement with the observation by
Hava et al. [10], 12 genes (7%) are involved in transcription. All of
the mutants in this category carried mutations in the genes
encoding transcription factors except strain 94E07, which
harbored an insertion in the 39 end of rpoD (encoding sigma-70
subunit of RNA polymerase). To our surprise, some of the
attenuated mutants represent the genes encoding 6 aminoacyl-
tRNA synthetases, which include leucyl-tRNA synthetase that was
previously identified in the TIGR4 STM study in a lung infection
model [10]. This study also identified several surface-associated
proteins including pneumococcal surface protein A (PspA) and
choline binding protein A (CbpA). PspA and CbpA are well-
described virulence factors for nasopharyngeal colonization and
lung infection of S. pneumoniae [22–24]. Both PspA and CbpA were
also found in the lung infection STM study with strain TIGR4
[10], but this is the first study showing that these factors are also
required for ear infection. Finally, the largest class of the genes (66,
39%) has no defined functions. Virtually all of the ST556 unique
genes (35 out of 37) fall into this category. These include OM-
associated pneumococcal sequences P23 (TIGR4 SP405) and H10
(absent in TIGR4) recently identified by subtractive hybridization
[25]. As reported in other pneumococcal STM studies [10,11], we
did not identify any mutants that represent the capsule
biosynthetic gene cluster.
Identification of pneumococcal genes only required for
ear infection
Previous STM studies have indicated that certain pneumococcal
genes are only required for infection in a host tissue/organ-specific
fashion [10–12]. We thus tested whether all of the genes identified
from the OM model are required for pneumococcal nasal
colonization. We initially tested suitability of a chinchilla model
for pneumococcal nasopharyngeal colonization as previously
described by Chen et al. [26]. However, the pneumococci
recovered from the nasal washing of chinchillas infected by
ST556 derivatives were frequently experimentally contaminated
by indigenous microorganisms since these animals were typically
maintained in commercial ranches instead of the SPF conditions
where laboratory mice are typically raised. In addition, there was a
greater level of animal-to-animal inconsistency in terms of total
levels of the recovered pneumococci as compared with the mouse
model. These limitations prompted us to use a mouse model for
pneumococcal colonization in this analysis [27]. The mutants
identified in the 1
st round screen with the OM model were ‘‘re-
screened’’ in a murine model of nasal colonization with the same
mutant pools used for the 2
nd screen in the OM model (Fig. 3A).
To our surprise, this screen identified only 89 attenuated mutants
Figure 2. Construction of STM strains in ST556. (A) Sequence
diversity of the STM constructs. The pneumococcal DNA inserts from 7 E.
coli transformants (1–7) were released from the pID701t plasmid by
restriction digestion with XhoIa n dXbaI, which flanked the original SmaI
cloning site. DNA standards are indicated in kilobase (kb). (B)R a n d o m
plasmid insertions in ST556 chromosome. Genomic DNA preparations
fromseven ST556 STM strains(1–7) were digested byHindIII,separated by
agarose gel electrophoresis, and hybridized with plasmid-specific probe.
doi:10.1371/journal.pone.0002950.g002
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attenuated mutants in the OM model were readily detectable in
the output pools from the nasal lavages (Fig. 3B; Table S1). This
screen also identified 12 genes that are only required for nasal
colonization but not for ear infection (Table S2). This skewed
result was due to the fact that the mutants had been prescreened in
the OM model. Together, these data show that we have identified
a large number of OM-specific pneumococcal genes.
Confirmation of attenuation phenotype of selected
mutants
To verify the STM screen data, we generated deletion
mutations in SP0308 (transport), SP1448 (unknown), and tetM
(drug resistance) of strain ST556 by allelic replacement. The STM
strains representing these genes showed impaired fitness in the
middle ear but not during nasal colonization (Table S1). The
resulting mutants were used to perform co-infection experiments
in both OM and nasal colonization models. An isogenic DSP1732
mutant ST1601 was used as positive control for nasal colonization
since our preliminary study showed that this mutant was deficient
in nasal colonization (data not shown). SP1732, encoding an
eukaryotic-type membrane-associated serine/threonine protein
kinase [28], is required for pneumococcal virulence [29,30]. All
mutants displayed a similar growth rate as the wild type ST556 in
THY broth (data not shown). Bacteria were enumerated from the
ear fluid and nasal washing samples 3 days post infection. In line
with the STM screen results, the DSP0308 (ST1594) and DSP1448
(ST1603) mutants were attenuated by .1,000 fold in the middle
ear (Fig. 4A) but relatively normal in the nasal colonization
(Fig. 4B). Contrary to the STM results, the DtetM mutant ST1595
Figure 3. Negative selection of the STM strains. (A) Detection of the attenuated STM strains. The same input pool #3 was used to infect the
middle ears of chinchillas or nasopharynx of mice in the 2
nd round screen. The animals were sacrificed 3 days post infection to recover the bacteria
(output pool) from the middle ears (chinchillas) or nasopharynx (mouse). The input and output pools were compared by PCR amplification and
agarose gel electrophoresis. Pound signs (#) and asterisks (*) indicate the mutants that were missing in the output pools from the middle ear and
nasopharynx, respectively. (B) Schematic representation of the STM strains identified in the 2
nd round screen. The red and yellow colors indicate the
total numbers of the mutants that were attenuated only in the middle ear infection or nasal colonization, respectively. The mutants attenuated in
both models are represented by blue color. (C) Schematic representation of the genes identified in the 2
nd round screen as in (B).
doi:10.1371/journal.pone.0002950.g003
Table 1. Functional classification of pneumococcal genes
identified in this study
Category
No. of
Genes Functional description
Transport 34 Carbohydrates, amino acids, ion, nucleotides, and
others
Cellular processes 22 House-keeping enzymes/proteins
Nucleic acid
processing
13 Enzymes/proteins involved in DNA replication/
repairing and DNA/RNA cleavage
Transcription 12 Proteins associated with basic transcription and
transcriptional regulation
Translation 9 Enzymes/proteins involved in biosynthesis of
amino acid-charged tRNAs and protein synthesis
Biosynthesis 8 Amino acids, nucleic acids, and fatty acids
Surface 7 Proteins associated with cytoplasmic membrane
and cell wall
Cell division 4 Proteins required for cell separation and shape
Energy metabolism 3 Enzymes associated with ATP synthesis and
related functions
Drug resistance 1 Tetracycline resistance protein TetM
Unknown 66 Lack of defined functions with or without TIGR4
homologs
Total 169
doi:10.1371/journal.pone.0002950.t001
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discrepancy may be due to a polar effect in the STM strains.
Consistent with previous studies [29,30], the DSP1732 mutant
showed significant deficiency in both models. It should be
mentioned that we did not identify a SP1732 mutant in our
STM screen, thus indicating that our screen did not saturate the
ST556 genome. The co-infection experiments thus validated our
STM results that certain S. pneumoniae genes are only required for
ear infection.
As an effort to verify the essentiality of the potentially essential
genes identified in our screen, we attempted to delete each of the
six aminoacyl-tRNA synthetase genes for arginine, cysteine,
histidine, lysine, leucine, and threonine in strain ST556 by allelic
exchange with the Janus cassette. The arginyl-tRNA synthetase
gene (argS) appears to be essential since we failed to obtain any
viable argS deletion mutants in multiple trials. However, we have
successfully obtained deletion mutants with the other five genes.
All of these mutants were able to grow in THY broth, but the
growth rates were noticeably slower than that of the wild type
strain (data not shown). To further characterize these mutants,
primers representing the flanking regions of the target genes were
used to amplify the Janus Cassette by PCR. Restriction digestion
and DNA sequencing analysis of the PCR products showed that
the lysyl-tRNA synthetase gene (lysS) was completely replaced by
the Janus cassette (data not shown). Interestingly, a second PCR
amplicon was always present in each of the cysS, hisS, leuS, and thrS
mutants (represented in the supplemental Figure S1). This
amplicon in each of the mutants was always similar in size to
that of the corresponding wild type gene, suggesting the presence
of both the truncated and wild type aminoacyl-tRNA synthetase
genes in each of these mutants. To rule out the possibility of mixed
clonal populations in the mutant stocks, we isolated single colonies
for each of the cysS, hisS, leuS, and thrS mutants. The DNA
sequencing analysis revealed the presence of the Janus Cassette in
each of these five aminoacyl-tRNA synthetase genes. However, the
repeated experiments consistently showed the ‘‘wild type-like’’
PCR products in all of the clonal populations. The precise nature
of this observation remains to be defined. Together, while argS
appears to be essential, deletion mutants for lysS, cysS, hisS, leuS,
and thrS could be obtained.
Discussion
This study represents the first extensive search of bacterial factors
that are required for ear infection.Our STM screen identified a total
of 169 genes that are potentially required for ear infection from a
pneumococcal OM isolate. These include a set of genes that were
previously found to be important for pneumococcal infections in
other tissues. In particular, 23 genes described here were discovered
in at least one of the three previous STM studies using murine
models of pneumonia [10–12] and bacteremia [11] (Table S1).
Some of these genes represent well-characterized virulence deter-
minants such as CbpA, PspA, and RlrA. CbpA and PspA are the
surface-exposed proteins that have been implicated as bacterial
complement-resistance factors [24,31–33] or adhesin [22,34–36].
RlrAis a transcriptional activator for the rlrA pathogenicity islet [37],
which encodes the recently described pneumococcal pilus [38,39].
Although the rlrA pathogenicity islet is only present in some
pneumococcal strains/clones [40], our preliminary sequencing
analysis identified all of the seven genes of this locus in the ST556
genome including rlrA, srtD and rrgA (unpublished data). srtD encodes
a sortase that incorporates the RrgA protein into the pilus [38,39].
Interestingly, an srtD mutant (strain 29E04) was also attenuated in
our screen. Nelson et al. recently showed that the pilus promotes
pneumococcal adhesion [41]. These lines of evidence strongly
suggest that effective adhesion and tolerance to complement-
mediated host defense are common requirements for bacterial
infections in the middle ear and lung.
Our data suggest that genetic requirement for pneumococcal ear
infection greatly differs from that of nasal colonization in animal
models. Only 31% of the genes identified in the ear infection screen
were ‘‘rediscovered’’ in the nasal colonization model. The majority
of the identified genes should reflect the different selection pressure
between the middle ear and nasopharynx. Tissue/disease-specific
pneumococcal genes were also found in other STM studies [10–12].
Lau et al.performedparallelscreensofthe sametype-3mutant pools
in murine models of pneumonia and bacteremia, and found that
only a third of the attenuated strains were shared by both infection
models [11]. The OM-specific genes may be required for
pneumococcal fitness in terms of bacterial replication and survival
inthe middle ear. Someof these genes mayberequired for acquiring
certain nutrients that are uniquely present in the middle ear. In
agreement with this notion, the majority of the transport-related
genes identified in this study have not been reported in the previous
STM screens with the lung and bacteremia infection models. Unlike
the relative quiescent hostresponsetocolonizingpneumococci at the
nasopharynx [42], pneumococcal replication in the middle ear
typically induces strong inflammation (e.g. mucosal secretion and
recruitmentofleukocytes)[43].Evenundertheseadverseconditions,
S. pneumoniae is able to persist at high levels in the middle ears of
humans and animal models [18,20]. In this context, some of the
OM-specific genes described here, such as those encoding
transcriptional factors, are likely to participate in bacterial
adaptation in the middle ear. Lastly, some of the differences might
be caused by the genetic differences between the chinchilla and
mouse infection models. It would be ideal to use a singe animal
model but the inherent limitations for the chinchilla nasal
colonization model and mouse ear infection model have prevented
us from conducting these screens in the same animal model.
The majority of the genes described here have not been
reported in the previous STM studies using murine models of
pneumonia [10–12] and bacteremia [11]. Due to the lack of
complete sequence information for the type-3 [11] and type-19
[12] studies, we can only perform comparative analysis with the
type-4 STM screen in the murine pneumonia model [10].
Figure 4. Quantification of the attenuation with ST556 deletion
mutants. (A) Middle ear co-infection. Both the left and right ears of
chinchillas (n=3) were infected by tympanotomy with a 1:1 mixture of
the wild type and isogenic deletion mutants ST1594 (SP0308), ST1595
(tetM), ST1601 (SP1732, stkP) or ST1603 (SP1448). Each symbol
represents the CI value from a single ear of infected chinchillas. CI is
defined as the output CFU ratio (mutant/wild type) divided by the input
CFU ratio (mutant/wild type). Bar indicates the geometric mean CI value
for each group of chinchillas. Statistical significance was determined by
Student’s t test. *, P,0.05, **, P,0.01. (B) Nasal co-infection. BALB/c
mice (n=5) were intranasally infected as in (A). The data were analyzed
and presented as in (A).
doi:10.1371/journal.pone.0002950.g004
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is only a 25-gene overlap between the two screens (Table S1). As
discussed above, the outcomes of these studies have highlighted the
unique challenges that S. pneumoniae must face in the lungs and
middle ears. Some of the variations could be caused by genetic
variations between model animals and genome plasticity between
strains ST556 and TIGR4. This is exemplified by the identifica-
tion of many ST556 genes that are absent from the TIGR4
genome. A recent multi-genome comparison reveals that .50% of
pneumococcal genes are not present in all strains [44]. Additional
differences could be related to technical differences in two screens
including the methods of mutagenesis (insertion duplication vs.
transposon insertion) and mutant detection (PCR vs. Southern
hybridization). Finally, the precise outcome of an STM screen also
depends on the cutoff stringency since neither PCR- nor Southern
hybridization-based detection method is fully quantitative.
A list of presumptive essential genes were identified in our
screen such as those encoding the sigma 70 subunit of RNA
polymerase (rpoD) and aminoacyl-tRNA synthetases. The attenu-
ation phenotype of the rpoD mutant might be due to partial loss of
sigma-70 function since the insertion only truncated 67 nucleotides
from the 39 end of the coding region. Alternatively, this could be
due to a polar effect on the downstream genes since rpoD is in the
middle of an apparent operon. Most of aminoacyl-tRNA
synthetases are essential for bacterial survival and therefore
considered to be promising drug targets [45]. However, some
aminoacyl-tRNA synthetase functions can be compensated by
biochemical modification of tRNA charged with structurally related
amino acids (e.g., glutamate and glutamine) [46]. Some bacteria can
possess multiple enzymes to synthesize the same aminoacyl-tRNAs
as exemplified by the presence of two methionyl-tRNA synthetases
[47]. None of the aminoacyl-tRNA synthetases appear to have a
functional homolog in the TIGR4 genome. We are sequencing the
ST556 genome to discernthesepossibilities.Finally,itispossiblethat
the plasmidinsertions inthese aminoacyl-tRNAsynthetasegenesdid
not completely abolish the activities of these enzymes. This could
explain the result with the STM strains of the argS gene since the
arginyl-tRNA synthetase appears to be essential based on our failure
to obtain viable argS deletion mutants. It is intriguing that the
deletion mutants of the cysS, hisS, thrS,a n dleuS genes appeared to
carry both the truncated and wild type alleles. We are in the process
of characterizing these mutants. It should be noted that pneumo-
coccal leucyl-tRNA synthetase was also identified by Hava etal. [10].
Some of the well-documented virulence factors for pneumococcal
colonization and invasive infections were not represented in our
screen. This can be explained by multiple possibilities. Some of the
misses might be due to the incomplete coverage of STM genomes by
our STM library. It is also possible that some of the virulence factors
identified in other infection models are not required for ear infection
as suggested by our data. Lastly, the lack of other genes could be
caused by the defective growth of the relevant mutants. As reported
with strain TIGR4 [10], we found that the capsule biosynthesis (cps)
locus of ST556 is refractory to insertional mutations (unpublished
observation). This may explain why we did not identify a single
mutant in the capsule gene cluster. Some of the ST556 STM
mutants were excluded from this study simply due to their extremely
poor growth. Along this line, other complementary approaches are
highly desirable to study those conditionally essential genes.
The OM model used in this study can be readily adapted to
identify bacterial genes required for ear infection caused by
nontypeable H. influenzae and M. catarrhalis. A limitation of this
model is that direct inoculation of bacteria into the middle ears
across the tympanic membrane bypasses the early dissemination
stage from the nasopharynx. Therefore, the genes that are
involved in the bacterial dissemination process can be missed.
However, this approach will ensure the same start point for all
mutants such that factors associated with bacterial fitness in the
middle ears are equally represented in the screen procedure.
Together, this study has provided valuable information for future
investigations in genetic basis of ear infections caused by S.
pneumoniae and other bacterial pathogens.
Materials and Methods
Bacterial strains and cultivation
ST556 is a serotype-19F isolate from a patient with otitis media
[8]. ST556 was sensitive to chloramphenicol and kanamycin but
resistant to penicillin and tetracycline. Pneumococci were
routinely grown in THY broth or on tryptic soy agar (TSA) plates
containing 3% (v/v) sheep blood in the presence or absence of
indicated antibiotics as described [48]. E. coli cultures were grown
in Luria-Bertani (LB) broth or on LB agar plates. All ingredients
for bacterial culture media and other chemicals used in this work
were obtained from Sigma (St. Louis, MO) unless otherwise stated.
Characterization of strain ST556
Pneumococcal growth in the middle ear was monitored by non-
invasive imaging of bioluminescent bacteria in live chinchillas
(Chinchilla lanigera) with a Xenogen IVIS system (Alameda,
California) as described [19]. One-year-old female chinchillas
(Ryerson, Plymouth, OH) were infected with 10
4 CFU of
bioluminescent strain ST1493, a ST556 derivative carrying the
luxCDABE genes of Photorhabdus luminescens by tympanotomy [49].
The luxCDABE was PCR amplified with primers Pr1393 and
Pr1394 from genomic DNA of Xenogen Bioware strain Xen-11.
The primers used in this work are described in the Supplemental
Information (Table S3). Pneumococcal genomic DNA was
prepared by phenol-chloroform extraction as described [48].
Bioluminescent pneumococci were generated by transforming
ST556 with the gel-purified PCR product as described [48]. The
kanamycin-resistant transformants (400 mg/ml) were further tested
for bioluminescence with the IVIS system instrument according to
the manufacturer’s instructions. The ST556 capsule was visualized
by transmission electron microscopy as described [50].
Construction and in vivo selection of pneumococcal STM
strains
Derivatives of the suicide pID701t plasmid were used to construct
disruptive mutants in strain ST556 by insertion duplication
essentially as described [11]. Each of the 55 plasmids used in this
study contained a 52- base pairs (bp) unique tag sequence. ST556
genomic DNA was sheared by ultrasonicaton; DNA fragments of
300–700 bpwere isolatedbystandardsucrosedensitygradientultra-
centrifugation. The DNA fragments were treated with T4 DNA
polymerase and ligated into the SmaI site of pID701t. All molecular
biology reagents were purchased from New England Biolabs
(Beverly, MA). The resultant plasmids were transformed into E. coli
DH5a and selected for chloramphenicol resistance (25 mg/ml). E.
coli transformants harboring the same tags were pooled to prepare
plasmids for transformation of ST556 by natural transformation
[48]. Pneumococcal transformants were selected on TSA plates
containing chloramphenicol (6 mg/ml) and assembled in 96 sets so
that each of ,55 mutants in a single set was uniquely tagged. The
randomness of plasmid insertions in ST556 chromosome was
assessed by Southern hybridization with genome DNA preparations
of randomly selected STM strains as described [48].
Southern hybridization with genome DNA preparations of
randomly selected STM strains was carried out as described [48].
OM-Associated Bacterial Genes
PLoS ONE | www.plosone.org 6 August 2008 | Volume 3 | Issue 8 | e2950Restriction enzyme-digested genomic DNA fragments were
separated by agarose gel electrophoresis and visualized by staining
agarose gels with ethidium bromide (2 mg/ml). A plasmid-specific
probe representing the pID701t plasmid was amplified with
primers Pr213 and Pr214 and the PCR DIG Probe Synthesis Kit
as described by the supplier (Roche, Indianapolis, IN). Sizes of
DNA fragments were estimated based on DIG-labeled DNA
molecular weight standards (Roche).
The ST556 mutants were screened in a chinchilla model of OM
[18]. All animal infection procedures were in compliance with the
guidelines of the Institutional Animal Care and Use Committee
(IACUC). The input pools of the 1
st round screen were prepared
essentially as described [51]. The tagged ST556 mutants were
assembled in 96 sets of 55 mutants based on the sequence identity
of the tags. Approximately 10
4 CFU of each input pool were used
to infect both ears of two chinchillas by injecting 100 ml of the
input pool suspension across the tympanic membrane using 27-
gauge insulin syringes. The chinchillas were anesthetized with
intramuscular injection of ketamine HCl (12 mg/kg) and xylazine
(1.6 mg/kg) in PBS. Portions of the inoculums were diluted in PBS
and spread on TSA blood plates containing chloramphenicol
(6 mg/ml), ampicillin (1 mg/ml) and gentamycin (2 mg/ml) to
verify the infection dose and to generate input pool DNA
templates for subsequent PCR detection of tagged mutants. The
middle ears were monitored daily for signs of bacterial infection by
otoscopy. The animals were sacrificed 3 days post infection to
recover the pneumococci by washing each of the middle ears with
300 ml PBS. The lavages were partially plated on TSA blood
plates containing chloramphenicol to establish the output pools.
The bacteria in the output pools were grown in THY to prepare
genomic DNA for subsequent PCR detection of tagged mutants.
The mutants identified in the 1
st round screen were arranged into
pools of ,30 mutants for a 2
nd round screen in both the chinchilla
and mouse models as described above.
The screen experiments in the murine nasal colonization model
werecarried out essentially as described[27].Groups of threefemale
BALB/c mice from Taconic Farm (6–8 weeks old; Germantown,
NY) were each infected with a single input pool by intranasal
inoculation of 20 ml bacterial suspension (,10
5 CFU). The mice
were anesthetized with ketamine HCl (Fort Dodge Animal Health,
Fort Dodge, Iowa) and xylazine (Phoenix Scientific, St. Joseph, Mo.)
in PBS immediately prior to infection. Three days later, mice were
sacrificedtocollect nasal lavagesfrom eachof infected micebyretro-
tracheal washing with 500 ml PBS, and plated on antibiotic-
containing THY agar dishes to prepare output pools as described
above. We typically recovered .10
5 CFU of pneumococci from
each ear of infected chinchillas and .10
4 CFU from each infected
mouse 3 days post inoculation. We repeated all infection experi-
ments that either yielded low numbers of bacterial colonies in the
output pools (,10
4 CFU) or highly contaminated output colonies as
assessed by colony size and morphology.
PCR detection and sequence identification of the STM
strains
The presence of the tagged mutants in the input and output pools
was detected by PCR essentially as described [51]. All bacterial
colonies obtained with each of the input and output pools were
washed off from agar plates with 1 ml THY broth. A portion of the
bacterialsuspension(100 ml)wasusedtoinoculate10 mlTHYbroth
to prepare bacterial genomic DNA by phenol-chloroform extraction
[48]; the rest was stored at 280uC as a backup source. Each input
and output DNA template was tested in 55 PCR reactions, each of
which contained a tag-specific primer (not shown) and a common
primer based on the plasmid backbone (Pr385). The tag-specific
primers were synthesized based on our DNA sequence information
foreachof thetags [51].Tocompare theamplification profiles of the
input and output pools for the same mutant sets, PCR products were
separated in 1.2% agarose gels and visualized by staining agarose
gels with ethidium bromide (2 mg/ml). An STM strain was
considered to be attenuated for infection when no or substantially
decreased PCR products were observed from the output pools from
both ears of at least two infected chinchillas (n=4) or from nasal
lavages of at least three mice compared with a positive PCR signal
for the corresponding input pools.
Plasmid insertion sites in ST556 genome were determined by
DNA sequencing of bacterial genomic DNA using a plasmid-based
primer Pr289 as described [51]. The resulting DNA sequences were
used to perform homology searches against the GenBank databases.
DNA and protein sequence analyses were performed using the
DNASTAR Lasergene v7.1 for Macintosh (Madison, WI).
Construction of pneumococcal deletion mutants
Gene deletions were generated in strain ST556 by allelic
exchange as described [48,52]. Briefly, the up- and down-stream
regions of target genes were PCR amplified from ST556 genomic
DNA with primer pairs Pr1448/Pr1449 and Pr1450/Pr1451 for
tetM, Pr1437/Pr1438 and Pr1439/Pr1440 for SP0308, Pr1515/
Pr1516 and Pr1517/Pr1518 for SP1448, Pr1507/Pr1508 and
Pr1509/Pr1510 for SP1732/stkP, Pr1537/Pr1538 and Pr1539/
Pr1540 for cysS, Pr1541/Pr1542 and Pr1543/Pr1544 for hisS,
Pr1553/Pr1554 and Pr1555/Pr1556 for leuS, Pr1545/Pr1546 and
Pr1547/Pr1548 for lysS, and Pr1549/Pr1550 and Pr1551/Pr1552
for thrS. The PCR products were digested with XbaI (upstream
regions) or XhoI (downstream regions), and ligated to the XbaI/
XhoI-digested Janus cassette. The Janus cassette was amplified with
primers Pr1097/Pr1098 from genomic DNA of pneumococcal
strain ST588 [48]. To minimize sequence errors during PCR
amplifications, a high fidelity Phusion DNA polymerase (New
England Biolabs) was used for all PCR amplifications. The ligation
mixtures were used to transform ST556 as described [48]. The
transformants were selected for resistance to kanamycin and
subsequently analyzed for the loss of target sequences in the
ST556 chromosome by PCR amplification and DNA sequencing.
Co-infections
Co-infection experiments were carried out essentially as described
[51]. Broth cultures of wild type and isogenic mutants were separately
incubated to OD620 ,0.4, mixed in a 1:1ratio (v/v), and stocked with
15% glycerol (v/v). The CFU levels of the frozen stocks were
enumerated in the presence (mutant only) or absence (mutant plus
wild type) of kanamycin. The bacterial mixtures were diluted in PBS
and used to infect the middle ears of chinchillas (,4610
4 CFU/ear)
and nasopharynx of mice (2610
5 CFU/mouse) as described above.
The level of attenuation is expressed as the competitive index (CI),
which is defined as the output CFU ratio (mutant/wild type) divided
by the input CFU ratio (mutant/wild type).
Statistical analysis
Statistical significance was determined by Student’s t test. A P
value of #0.05 was considered significant.
Supporting Information
Figure S1 Deletion of aminoacyl-tRNA synthetase genes in
strain ST556. (A). Schematic illustration of allelic exchange. The
59 and 39 flanking sequences of the aminoacyl-tRNA synthetase
genes were PCR amplified, digested with Xba I and Xho I,
respectively. The digested PCR products were ligated to the Xba
OM-Associated Bacterial Genes
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gene) to perform allelic exchange as described in the ‘‘Materials
and Methods’’. This procedure resulted in kanamycin-resistant
strains ST1818 (cysS), ST1819 (hisS), ST1820 (lysS) (not shown),
ST1821 (thrS), and ST1822 (leuS). (B). PCR amplification of the
target gene loci. Each of the target aminoacyl-tRNA synthetase
genes was amplified from the wild type and corresponding mutant
strains with the flanking region-specific primers (e.g. Primers 1 and
4 in A). The PCR products were digested with Xho I to
differentiate the mutant alleles from the wild type counterparts.
Only the mutant alleles could be cut by Xho I. ST1595, a tetM
mutant of ST556 (see Fig. 4), was used as a positive control. It
should be noted that, in addition to the expected mutant allele,
each of the cysS, hisS, thrS, and leuS mutants appeared to carry
the wild type allele by an uncharacterized mechanism.
Found at: doi:10.1371/journal.pone.0002950.s001 (6.48 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0002950.s002 (0.65 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0002950.s003 (0.30 MB
DOC)
Table S3
Found at: doi:10.1371/journal.pone.0002950.s004 (0.31 MB
DOC)
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